

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.77747791 |
| 2 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.77747791 |
| 3 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.77747791 |
| 4 | negative regulation of DNA repair (GO:0045738) | 4.38716323 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38333278 |
| 6 | protein localization to chromosome, centromeric region (GO:0071459) | 3.77414919 |
| 7 | cell adhesion mediated by integrin (GO:0033627) | 3.65847961 |
| 8 | positive regulation of chromosome segregation (GO:0051984) | 3.65228851 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58197866 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57987240 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57987240 |
| 12 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.56701528 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 3.53576067 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44033358 |
| 15 | protein K11-linked deubiquitination (GO:0035871) | 3.38461460 |
| 16 | regulation of centriole replication (GO:0046599) | 3.37071908 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36676424 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.36676424 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36676424 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36676424 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36676424 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.36676424 |
| 23 | protein localization to kinetochore (GO:0034501) | 3.36003578 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.35078113 |
| 25 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.34730051 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 3.33628921 |
| 27 | COPII vesicle coating (GO:0048208) | 3.24768623 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.21371393 |
| 29 | establishment of chromosome localization (GO:0051303) | 3.17121598 |
| 30 | non-recombinational repair (GO:0000726) | 3.14327238 |
| 31 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.14327238 |
| 32 | nuclear pore complex assembly (GO:0051292) | 3.13670075 |
| 33 | sister chromatid segregation (GO:0000819) | 3.11430343 |
| 34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10632951 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.10121320 |
| 36 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.09795842 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.08117589 |
| 38 | response to X-ray (GO:0010165) | 3.03358612 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 3.00648745 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 3.00648745 |
| 41 | metaphase plate congression (GO:0051310) | 2.99727407 |
| 42 | mitotic metaphase plate congression (GO:0007080) | 2.98597833 |
| 43 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.96569022 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95126027 |
| 45 | cellular response to vitamin D (GO:0071305) | 2.95031640 |
| 46 | mitotic sister chromatid segregation (GO:0000070) | 2.91997201 |
| 47 | B cell mediated immunity (GO:0019724) | 2.91826778 |
| 48 | regulation of sister chromatid cohesion (GO:0007063) | 2.90533971 |
| 49 | regulation of RNA export from nucleus (GO:0046831) | 2.89483162 |
| 50 | nuclear pore organization (GO:0006999) | 2.87202818 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 2.84643101 |
| 52 | mitotic G2/M transition checkpoint (GO:0044818) | 2.82913317 |
| 53 | hepatocyte apoptotic process (GO:0097284) | 2.82866852 |
| 54 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.81955244 |
| 55 | natural killer cell mediated immunity (GO:0002228) | 2.81955244 |
| 56 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.79449593 |
| 57 | response to interferon-alpha (GO:0035455) | 2.78647713 |
| 58 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.75684914 |
| 59 | histone-serine phosphorylation (GO:0035404) | 2.75423518 |
| 60 | spindle assembly involved in mitosis (GO:0090307) | 2.74948153 |
| 61 | pore complex assembly (GO:0046931) | 2.73729901 |
| 62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.73074269 |
| 63 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71923682 |
| 64 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.70910756 |
| 65 | cytokine secretion (GO:0050663) | 2.70849383 |
| 66 | response to peptidoglycan (GO:0032494) | 2.70801426 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 2.67894691 |
| 68 | DNA geometric change (GO:0032392) | 2.66941666 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65968428 |
| 70 | wound healing, spreading of epidermal cells (GO:0035313) | 2.63899180 |
| 71 | DNA duplex unwinding (GO:0032508) | 2.63473033 |
| 72 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.62508304 |
| 73 | membrane raft organization (GO:0031579) | 2.62078233 |
| 74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59635186 |
| 75 | pinocytosis (GO:0006907) | 2.59359181 |
| 76 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.59275921 |
| 77 | response to muramyl dipeptide (GO:0032495) | 2.59247703 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 2.58250948 |
| 79 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.56794636 |
| 80 | embryonic process involved in female pregnancy (GO:0060136) | 2.56469398 |
| 81 | response to type I interferon (GO:0034340) | 2.54582133 |
| 82 | cellular response to interferon-alpha (GO:0035457) | 2.54069030 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53556623 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52700479 |
| 85 | signal peptide processing (GO:0006465) | 2.51997824 |
| 86 | type I interferon signaling pathway (GO:0060337) | 2.51386999 |
| 87 | cellular response to type I interferon (GO:0071357) | 2.51386999 |
| 88 | regulation of centrosome duplication (GO:0010824) | 2.50367493 |
| 89 | neutrophil activation (GO:0042119) | 2.49823690 |
| 90 | endosome to melanosome transport (GO:0035646) | 2.49677979 |
| 91 | endosome to pigment granule transport (GO:0043485) | 2.49677979 |
| 92 | regulation of centrosome cycle (GO:0046605) | 2.48657138 |
| 93 | snRNA transcription (GO:0009301) | 2.47436162 |
| 94 | regulation of integrin activation (GO:0033623) | 2.47347816 |
| 95 | positive regulation of protein autophosphorylation (GO:0031954) | 2.46058523 |
| 96 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.45901035 |
| 97 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.45901035 |
| 98 | negative thymic T cell selection (GO:0045060) | 2.45680839 |
| 99 | granulocyte activation (GO:0036230) | 2.44320760 |
| 100 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.44305122 |
| 101 | isotype switching (GO:0045190) | 2.44305122 |
| 102 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.44305122 |
| 103 | replication fork processing (GO:0031297) | 2.43384902 |
| 104 | mitotic cytokinesis (GO:0000281) | 2.42455271 |
| 105 | regulation of chromosome segregation (GO:0051983) | 2.42332210 |
| 106 | regulation of Rac protein signal transduction (GO:0035020) | 2.40712794 |
| 107 | sphingosine metabolic process (GO:0006670) | 2.40243306 |
| 108 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39253934 |
| 109 | nuclear envelope organization (GO:0006998) | 2.38393763 |
| 110 | response to UV-C (GO:0010225) | 2.37592562 |
| 111 | regulation of necroptotic process (GO:0060544) | 2.37477291 |
| 112 | actin nucleation (GO:0045010) | 2.36447839 |
| 113 | negative T cell selection (GO:0043383) | 2.35884035 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35614445 |
| 115 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.35052783 |
| 116 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.34626991 |
| 117 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.34123022 |
| 118 | regulation of sister chromatid segregation (GO:0033045) | 2.34123022 |
| 119 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.34123022 |
| 120 | regulation of B cell differentiation (GO:0045577) | 2.33502795 |
| 121 | negative regulation of B cell proliferation (GO:0030889) | 2.33455800 |
| 122 | natural killer cell differentiation (GO:0001779) | 2.33007246 |
| 123 | positive regulation of isotype switching (GO:0045830) | 2.32964179 |
| 124 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.32800817 |
| 125 | T-helper 1 type immune response (GO:0042088) | 2.31939558 |
| 126 | replicative senescence (GO:0090399) | 2.31215464 |
| 127 | cellular response to virus (GO:0098586) | 2.29813205 |
| 128 | Golgi organization (GO:0007030) | 2.29771322 |
| 129 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.29683837 |
| 130 | spindle checkpoint (GO:0031577) | 2.29586002 |
| 131 | mitotic nuclear envelope disassembly (GO:0007077) | 2.29410526 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.29255623 |
| 133 | macrophage activation involved in immune response (GO:0002281) | 2.29010150 |
| 134 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.28870720 |
| 135 | cellular response to ethanol (GO:0071361) | 2.27732252 |
| 136 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.27224647 |
| 137 | DNA conformation change (GO:0071103) | 2.25935218 |
| 138 | glomerular visceral epithelial cell development (GO:0072015) | 2.25475387 |
| 139 | myelin assembly (GO:0032288) | 2.25469140 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.25243658 |
| 141 | positive regulation of antigen processing and presentation (GO:0002579) | 2.24983981 |
| 142 | regulation of interferon-beta production (GO:0032648) | 2.24873432 |
| 143 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.24323146 |
| 144 | regulation of spindle organization (GO:0090224) | 2.23530435 |
| 145 | skin morphogenesis (GO:0043589) | 2.22538064 |
| 146 | leukocyte aggregation (GO:0070486) | 2.21568391 |
| 147 | histone mRNA catabolic process (GO:0071044) | 2.21027834 |
| 148 | cellular response to ionizing radiation (GO:0071479) | 2.20444683 |
| 149 | inner cell mass cell proliferation (GO:0001833) | 2.19993413 |
| 150 | pre-miRNA processing (GO:0031054) | 2.19977777 |
| 151 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.19660211 |
| 152 | pericardium development (GO:0060039) | 2.19445645 |
| 153 | iron ion import (GO:0097286) | 2.19302699 |
| 154 | protein localization to chromosome (GO:0034502) | 2.19077308 |
| 155 | positive regulation of macrophage differentiation (GO:0045651) | 2.18837701 |
| 156 | cellular extravasation (GO:0045123) | 2.18796938 |
| 157 | positive regulation of defense response to virus by host (GO:0002230) | 2.18451197 |
| 158 | hemidesmosome assembly (GO:0031581) | 2.17771027 |
| 159 | ventricular cardiac muscle cell development (GO:0055015) | 2.17403213 |
| 160 | interkinetic nuclear migration (GO:0022027) | 2.16890480 |
| 161 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.16721084 |
| 162 | positive thymic T cell selection (GO:0045059) | 2.15147366 |
| 163 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.15043800 |
| 164 | mitotic sister chromatid cohesion (GO:0007064) | 2.14719674 |
| 165 | heterochromatin organization (GO:0070828) | 2.14686005 |
| 166 | T cell apoptotic process (GO:0070231) | 2.14681296 |
| 167 | low-density lipoprotein particle clearance (GO:0034383) | 2.12603208 |
| 168 | myeloid dendritic cell activation (GO:0001773) | 2.12068364 |
| 169 | apoptotic cell clearance (GO:0043277) | 2.11527186 |
| 170 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.11444371 |
| 171 | negative regulation of viral genome replication (GO:0045071) | 2.11420282 |
| 172 | nuclear envelope disassembly (GO:0051081) | 2.10454486 |
| 173 | membrane disassembly (GO:0030397) | 2.10454486 |
| 174 | negative regulation of granulocyte differentiation (GO:0030853) | 2.10019560 |
| 175 | leukocyte cell-cell adhesion (GO:0007159) | 2.09604465 |
| 176 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.07328162 |
| 177 | response to host immune response (GO:0052572) | 2.07255010 |
| 178 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.07255010 |
| 179 | regulation of cholesterol storage (GO:0010885) | 2.06393498 |
| 180 | regulation of response to interferon-gamma (GO:0060330) | 2.06020508 |
| 181 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.05661068 |
| 182 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.05295605 |
| 183 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.04925855 |
| 184 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.04473925 |
| 185 | response to host (GO:0075136) | 2.04473925 |
| 186 | response to host defenses (GO:0052200) | 2.04473925 |
| 187 | regulation of interleukin-12 production (GO:0032655) | 2.03487202 |
| 188 | mitotic chromosome condensation (GO:0007076) | 2.03290326 |
| 189 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.02922687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76208504 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30754864 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.11093615 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.62641810 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09584527 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91581465 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.86815142 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78323773 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70521900 |
| 10 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.59980198 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56158692 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46628940 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.46295155 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44793605 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43072854 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41989344 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39911950 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34497059 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.26040697 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24964966 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23862467 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.21416913 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16009332 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.13394472 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11468608 |
| 26 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.07494603 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04611539 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.03921443 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00742315 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99489392 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88814643 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87231337 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.85877796 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85693527 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.83420356 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83220537 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.80140188 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80119231 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78700386 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78285588 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77321047 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76877405 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73998711 |
| 44 | * MYB_26560356_Chip-Seq_TH1_Human | 1.72173549 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.68576895 |
| 46 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67834414 |
| 47 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66142229 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65018048 |
| 49 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63682809 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63333085 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61399986 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.61269649 |
| 53 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58377172 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55503798 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52991211 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52863541 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51415162 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51312327 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50281252 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48780111 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44157226 |
| 62 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.42667449 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.42298863 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42201230 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39418498 |
| 66 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32600367 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32534058 |
| 68 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32141967 |
| 69 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.30468051 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29353260 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28359359 |
| 72 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27850694 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27282250 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26575323 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26279115 |
| 76 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.26025582 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24197605 |
| 78 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24046453 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23428814 |
| 80 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.22551539 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20314925 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19416537 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19322988 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19283189 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18433998 |
| 86 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17180386 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17055206 |
| 88 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16723723 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14888572 |
| 90 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.14411747 |
| 91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12591805 |
| 92 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11948835 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11942520 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.11390680 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11252236 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11030166 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08985531 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08747904 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08571370 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07780713 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06907214 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06313538 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06313538 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05515036 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05159468 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03691592 |
| 107 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.03049168 |
| 108 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02859528 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02534268 |
| 110 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00695504 |
| 111 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00181462 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99892655 |
| 113 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99493524 |
| 114 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99265293 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98991703 |
| 116 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98246255 |
| 117 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97971667 |
| 118 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.95507127 |
| 119 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95341269 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94990928 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 0.94656558 |
| 122 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93652433 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92496276 |
| 124 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92020081 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91789084 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91700723 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91524207 |
| 128 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91442242 |
| 129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91085818 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90776488 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90763495 |
| 132 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.90337531 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90212697 |
| 134 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89583434 |
| 135 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.88726252 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88541324 |
| 137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88454646 |
| 138 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.88279273 |
| 139 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.87598620 |
| 140 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87529820 |
| 141 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.86761499 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85541971 |
| 143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84902044 |
| 144 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84200657 |
| 145 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84136824 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83995610 |
| 147 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83898727 |
| 148 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.83584116 |
| 149 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83335193 |
| 150 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82874236 |
| 151 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82858120 |
| 152 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82858120 |
| 153 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82738821 |
| 154 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82274719 |
| 155 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82078043 |
| 156 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81569182 |
| 157 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80356610 |
| 158 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.79477480 |
| 159 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78483517 |
| 160 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78267364 |
| 161 | GATA3_26560356_Chip-Seq_TH2_Human | 0.76631181 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75993590 |
| 163 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75175234 |
| 164 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74764652 |
| 165 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.74593988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.10007372 |
| 2 | MP0003950_abnormal_plasma_membrane | 2.98512134 |
| 3 | MP0003436_decreased_susceptibility_to | 2.36857998 |
| 4 | MP0000685_abnormal_immune_system | 2.27500703 |
| 5 | * MP0000569_abnormal_digit_pigmentation | 2.27001792 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.26234596 |
| 7 | MP0009785_altered_susceptibility_to | 2.09836454 |
| 8 | MP0005671_abnormal_response_to | 2.05873802 |
| 9 | MP0009697_abnormal_copulation | 1.97669556 |
| 10 | MP0005000_abnormal_immune_tolerance | 1.97101255 |
| 11 | MP0010307_abnormal_tumor_latency | 1.96867015 |
| 12 | MP0002419_abnormal_innate_immunity | 1.94352376 |
| 13 | MP0003300_gastrointestinal_ulcer | 1.93802292 |
| 14 | MP0002452_abnormal_antigen_presenting | 1.93148878 |
| 15 | MP0005076_abnormal_cell_differentiation | 1.92806387 |
| 16 | MP0001800_abnormal_humoral_immune | 1.92273992 |
| 17 | MP0010678_abnormal_skin_adnexa | 1.92110437 |
| 18 | MP0002396_abnormal_hematopoietic_system | 1.91291047 |
| 19 | * MP0005025_abnormal_response_to | 1.89540332 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.89349319 |
| 21 | MP0009278_abnormal_bone_marrow | 1.86641473 |
| 22 | * MP0005408_hypopigmentation | 1.86540513 |
| 23 | MP0001790_abnormal_immune_system | 1.86067024 |
| 24 | MP0005387_immune_system_phenotype | 1.86067024 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.83401862 |
| 26 | MP0006082_CNS_inflammation | 1.82897280 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.81312884 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.81152096 |
| 29 | MP0004947_skin_inflammation | 1.79692458 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.79493916 |
| 31 | MP0003941_abnormal_skin_development | 1.78708172 |
| 32 | MP0002723_abnormal_immune_serum | 1.77005612 |
| 33 | MP0003303_peritoneal_inflammation | 1.73098213 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.72158022 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.72158022 |
| 36 | MP0003724_increased_susceptibility_to | 1.69554634 |
| 37 | MP0001819_abnormal_immune_cell | 1.67871825 |
| 38 | MP0002006_tumorigenesis | 1.67799229 |
| 39 | MP0004272_abnormal_basement_membrane | 1.66838328 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.66401694 |
| 41 | * MP0005464_abnormal_platelet_physiology | 1.59211469 |
| 42 | * MP0002398_abnormal_bone_marrow | 1.57092529 |
| 43 | * MP0002405_respiratory_system_inflammati | 1.56934032 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.55866558 |
| 45 | MP0003448_altered_tumor_morphology | 1.54635966 |
| 46 | MP0000858_altered_metastatic_potential | 1.49247737 |
| 47 | * MP0005058_abnormal_lysosome_morphology | 1.46250027 |
| 48 | MP0008058_abnormal_DNA_repair | 1.44866984 |
| 49 | * MP0000716_abnormal_immune_system | 1.43225681 |
| 50 | MP0008057_abnormal_DNA_replication | 1.41243501 |
| 51 | MP0002060_abnormal_skin_morphology | 1.39942126 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.39273930 |
| 53 | MP0006054_spinal_hemorrhage | 1.38645047 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.37926249 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.37764564 |
| 56 | MP0000427_abnormal_hair_cycle | 1.35897904 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.35206478 |
| 58 | MP0002009_preneoplasia | 1.34417529 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.33194690 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.32952886 |
| 61 | MP0002722_abnormal_immune_system | 1.32227999 |
| 62 | MP0000383_abnormal_hair_follicle | 1.32224311 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.31815245 |
| 64 | MP0000490_abnormal_crypts_of | 1.30670312 |
| 65 | MP0003077_abnormal_cell_cycle | 1.29601793 |
| 66 | MP0004510_myositis | 1.27218928 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.26670268 |
| 68 | * MP0002429_abnormal_blood_cell | 1.26203343 |
| 69 | MP0001853_heart_inflammation | 1.25487976 |
| 70 | MP0005275_abnormal_skin_tensile | 1.23592406 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.23085790 |
| 72 | MP0010094_abnormal_chromosome_stability | 1.21894642 |
| 73 | MP0005023_abnormal_wound_healing | 1.21540940 |
| 74 | MP0003111_abnormal_nucleus_morphology | 1.21466211 |
| 75 | MP0001873_stomach_inflammation | 1.20691747 |
| 76 | * MP0000371_diluted_coat_color | 1.16857698 |
| 77 | MP0008469_abnormal_protein_level | 1.13316425 |
| 78 | MP0003984_embryonic_growth_retardation | 1.12113835 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.11591349 |
| 80 | MP0005310_abnormal_salivary_gland | 1.11313963 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.11291861 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.10622825 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 1.10562209 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.10455776 |
| 85 | MP0001672_abnormal_embryogenesis/_devel | 1.09338554 |
| 86 | MP0005380_embryogenesis_phenotype | 1.09338554 |
| 87 | MP0001697_abnormal_embryo_size | 1.08808048 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.07617990 |
| 89 | MP0009840_abnormal_foam_cell | 1.06329227 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 1.04924877 |
| 91 | MP0000703_abnormal_thymus_morphology | 1.04206093 |
| 92 | MP0003091_abnormal_cell_migration | 1.01039553 |
| 93 | MP0008007_abnormal_cellular_replicative | 1.00824718 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.99644519 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.99566927 |
| 96 | * MP0003172_abnormal_lysosome_physiology | 0.99537100 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.99269654 |
| 98 | MP0004957_abnormal_blastocyst_morpholog | 0.98348192 |
| 99 | MP0009764_decreased_sensitivity_to | 0.97910298 |
| 100 | MP0002084_abnormal_developmental_patter | 0.97073486 |
| 101 | MP0001849_ear_inflammation | 0.96931494 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.96438909 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.96340113 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.96125021 |
| 105 | MP0001661_extended_life_span | 0.95263650 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.95077868 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.92498550 |
| 108 | MP0000350_abnormal_cell_proliferation | 0.91275198 |
| 109 | MP0003195_calcinosis | 0.90876255 |
| 110 | MP0000358_abnormal_cell_content/ | 0.90559347 |
| 111 | MP0001243_abnormal_dermal_layer | 0.88600848 |
| 112 | MP0002254_reproductive_system_inflammat | 0.88152268 |
| 113 | MP0000377_abnormal_hair_follicle | 0.87997434 |
| 114 | MP0000733_abnormal_muscle_development | 0.87432021 |
| 115 | MP0003045_fibrosis | 0.86961223 |
| 116 | MP0002168_other_aberrant_phenotype | 0.86954251 |
| 117 | MP0000627_abnormal_mammary_gland | 0.83952522 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.83857751 |
| 119 | MP0000343_altered_response_to | 0.83687595 |
| 120 | * MP0005174_abnormal_tail_pigmentation | 0.83426731 |
| 121 | MP0005395_other_phenotype | 0.82906340 |
| 122 | MP0002086_abnormal_extraembryonic_tissu | 0.82883688 |
| 123 | MP0001191_abnormal_skin_condition | 0.81117913 |
| 124 | MP0002933_joint_inflammation | 0.80105723 |
| 125 | MP0009763_increased_sensitivity_to | 0.79753631 |
| 126 | MP0005621_abnormal_cell_physiology | 0.79144018 |
| 127 | MP0000372_irregular_coat_pigmentation | 0.79099562 |
| 128 | MP0000598_abnormal_liver_morphology | 0.78816924 |
| 129 | MP0003828_pulmonary_edema | 0.78695491 |
| 130 | MP0008260_abnormal_autophagy | 0.78224378 |
| 131 | MP0003718_maternal_effect | 0.77064068 |
| 132 | MP0003866_abnormal_defecation | 0.76713378 |
| 133 | MP0005384_cellular_phenotype | 0.76165066 |
| 134 | MP0001915_intracranial_hemorrhage | 0.75389582 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.74902905 |
| 136 | MP0001730_embryonic_growth_arrest | 0.74774281 |
| 137 | MP0005197_abnormal_uvea_morphology | 0.73958588 |
| 138 | MP0004233_abnormal_muscle_weight | 0.73395721 |
| 139 | MP0000313_abnormal_cell_death | 0.73337498 |
| 140 | * MP0001186_pigmentation_phenotype | 0.72731343 |
| 141 | MP0003252_abnormal_bile_duct | 0.72335100 |
| 142 | MP0001958_emphysema | 0.72171736 |
| 143 | MP0005390_skeleton_phenotype | 0.71807797 |
| 144 | MP0004197_abnormal_fetal_growth/weight/ | 0.71434472 |
| 145 | MP0003186_abnormal_redox_activity | 0.71154677 |
| 146 | MP0010234_abnormal_vibrissa_follicle | 0.70880117 |
| 147 | MP0001881_abnormal_mammary_gland | 0.70665453 |
| 148 | MP0002080_prenatal_lethality | 0.69946015 |
| 149 | MP0003279_aneurysm | 0.69016926 |
| 150 | MP0002085_abnormal_embryonic_tissue | 0.67512518 |
| 151 | MP0003868_abnormal_feces_composition | 0.66735517 |
| 152 | MP0003786_premature_aging | 0.65751134 |
| 153 | MP0000428_abnormal_craniofacial_morphol | 0.64983725 |
| 154 | MP0005248_abnormal_Harderian_gland | 0.64482323 |
| 155 | MP0004883_abnormal_blood_vessel | 0.61890349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.51781989 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.01499370 |
| 3 | Chromsome breakage (HP:0040012) | 3.93930971 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.81324612 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.71154579 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.58132064 |
| 7 | Papillary thyroid carcinoma (HP:0002895) | 3.54266132 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49944264 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.23582324 |
| 10 | Premature rupture of membranes (HP:0001788) | 3.20638195 |
| 11 | Orthostatic hypotension (HP:0001278) | 3.01398461 |
| 12 | Recurrent viral infections (HP:0004429) | 3.00915024 |
| 13 | Rhabdomyosarcoma (HP:0002859) | 2.95649958 |
| 14 | Myositis (HP:0100614) | 2.88744227 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.84897919 |
| 16 | Abnormality of chromosome stability (HP:0003220) | 2.84460212 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.82654143 |
| 18 | Thyroid carcinoma (HP:0002890) | 2.79714807 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76556461 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76556461 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76556461 |
| 22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66730730 |
| 23 | Osteolytic defects of the hand bones (HP:0009699) | 2.66730730 |
| 24 | Thrombocytosis (HP:0001894) | 2.63110207 |
| 25 | Biliary tract neoplasm (HP:0100574) | 2.62700800 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61893545 |
| 27 | Myocardial infarction (HP:0001658) | 2.60441514 |
| 28 | Orchitis (HP:0100796) | 2.58628072 |
| 29 | Arterial thrombosis (HP:0004420) | 2.55854220 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 2.53839647 |
| 31 | Pustule (HP:0200039) | 2.53262537 |
| 32 | Abnormality of the fingertips (HP:0001211) | 2.51080768 |
| 33 | Nasal polyposis (HP:0100582) | 2.50071897 |
| 34 | Cutaneous melanoma (HP:0012056) | 2.47131780 |
| 35 | Cellulitis (HP:0100658) | 2.46505975 |
| 36 | Recurrent skin infections (HP:0001581) | 2.40955430 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40158349 |
| 38 | Abnormal biliary tract morphology (HP:0012440) | 2.39772609 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.39615659 |
| 40 | IgM deficiency (HP:0002850) | 2.39098649 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.38928605 |
| 42 | Hematochezia (HP:0002573) | 2.35964302 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.35795494 |
| 44 | Optic neuritis (HP:0100653) | 2.35795494 |
| 45 | Gingivitis (HP:0000230) | 2.34890870 |
| 46 | Curly hair (HP:0002212) | 2.34837852 |
| 47 | * Periodontitis (HP:0000704) | 2.34690672 |
| 48 | Gingival bleeding (HP:0000225) | 2.34252050 |
| 49 | Absent frontal sinuses (HP:0002688) | 2.33404530 |
| 50 | Deep philtrum (HP:0002002) | 2.32808605 |
| 51 | Entropion (HP:0000621) | 2.31945149 |
| 52 | Vasculitis (HP:0002633) | 2.30932437 |
| 53 | Syringomyelia (HP:0003396) | 2.30072044 |
| 54 | Spinal cord lesions (HP:0100561) | 2.30072044 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.29805819 |
| 56 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.28583425 |
| 57 | Esophageal varix (HP:0002040) | 2.26822346 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.25158348 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.24272602 |
| 60 | Thoracolumbar scoliosis (HP:0002944) | 2.23415337 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.23258809 |
| 62 | IgA deficiency (HP:0002720) | 2.22644159 |
| 63 | Neoplasm of the small intestine (HP:0100833) | 2.22570756 |
| 64 | Volvulus (HP:0002580) | 2.20476461 |
| 65 | Asymmetry of the thorax (HP:0001555) | 2.19063416 |
| 66 | Embryonal renal neoplasm (HP:0011794) | 2.17264321 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.16621844 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14114120 |
| 69 | Obstructive lung disease (HP:0006536) | 2.14114120 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.13715065 |
| 71 | Aortic dissection (HP:0002647) | 2.12859921 |
| 72 | Abnormality of T cells (HP:0002843) | 2.12858032 |
| 73 | B lymphocytopenia (HP:0010976) | 2.11677413 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.11111935 |
| 75 | T lymphocytopenia (HP:0005403) | 2.10655268 |
| 76 | Bladder neoplasm (HP:0009725) | 2.09988207 |
| 77 | Bladder carcinoma (HP:0002862) | 2.09988207 |
| 78 | Neoplasm of the rectum (HP:0100743) | 2.09603304 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.08523380 |
| 80 | Petechiae (HP:0000967) | 2.08321543 |
| 81 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.07215254 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06237784 |
| 83 | Amaurosis fugax (HP:0100576) | 2.05928250 |
| 84 | Ascites (HP:0001541) | 2.04709530 |
| 85 | Metaphyseal irregularity (HP:0003025) | 2.04231921 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.03861455 |
| 87 | Leukocytosis (HP:0001974) | 2.03585630 |
| 88 | Prostate neoplasm (HP:0100787) | 2.02703934 |
| 89 | Agnosia (HP:0010524) | 2.02136669 |
| 90 | Neoplasm of striated muscle (HP:0009728) | 2.02023198 |
| 91 | Abnormal foot bone ossification (HP:0010675) | 2.01902138 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98214535 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98214535 |
| 94 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.96927427 |
| 95 | Soft skin (HP:0000977) | 1.95859496 |
| 96 | Acute myeloid leukemia (HP:0004808) | 1.94249599 |
| 97 | Osteomyelitis (HP:0002754) | 1.93859442 |
| 98 | Cone-rod dystrophy (HP:0000548) | 1.93854916 |
| 99 | Coarse hair (HP:0002208) | 1.92315454 |
| 100 | Arterial tortuosity (HP:0005116) | 1.91658086 |
| 101 | Eosinophilia (HP:0001880) | 1.91601895 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 1.91063720 |
| 103 | Inflammation of the large intestine (HP:0002037) | 1.90685367 |
| 104 | Autoamputation (HP:0001218) | 1.90337313 |
| 105 | Prolonged bleeding time (HP:0003010) | 1.90216809 |
| 106 | Cervical subluxation (HP:0003308) | 1.89552563 |
| 107 | Vertebral compression fractures (HP:0002953) | 1.89363271 |
| 108 | Increased mean platelet volume (HP:0011877) | 1.88908704 |
| 109 | Pulmonary infiltrates (HP:0002113) | 1.88852601 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.88776568 |
| 111 | Anhidrosis (HP:0000970) | 1.88142068 |
| 112 | Protrusio acetabuli (HP:0003179) | 1.87901840 |
| 113 | Abnormal platelet function (HP:0011869) | 1.87828209 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.87828209 |
| 115 | Pulmonic stenosis (HP:0001642) | 1.87455178 |
| 116 | Vascular tortuosity (HP:0004948) | 1.86875101 |
| 117 | Combined immunodeficiency (HP:0005387) | 1.86062946 |
| 118 | Anorexia (HP:0002039) | 1.85715326 |
| 119 | * Fair hair (HP:0002286) | 1.85680586 |
| 120 | Colitis (HP:0002583) | 1.84827190 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 1.84713023 |
| 122 | Epistaxis (HP:0000421) | 1.84427830 |
| 123 | Aortic aneurysm (HP:0004942) | 1.84171500 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 1.84029888 |
| 125 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.82300005 |
| 126 | Renal cortical cysts (HP:0000803) | 1.82291734 |
| 127 | Poor head control (HP:0002421) | 1.81908889 |
| 128 | Granulocytopenia (HP:0001913) | 1.81744075 |
| 129 | Thin bony cortex (HP:0002753) | 1.81592682 |
| 130 | Chronic otitis media (HP:0000389) | 1.80925165 |
| 131 | Breast carcinoma (HP:0003002) | 1.80314900 |
| 132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.79864935 |
| 133 | Chest pain (HP:0100749) | 1.79196600 |
| 134 | Meckel diverticulum (HP:0002245) | 1.79027648 |
| 135 | Symptomatic seizures (HP:0011145) | 1.78577066 |
| 136 | Vascular calcification (HP:0004934) | 1.77835947 |
| 137 | Spondylolisthesis (HP:0003302) | 1.77407765 |
| 138 | Meningitis (HP:0001287) | 1.76901747 |
| 139 | Barrel-shaped chest (HP:0001552) | 1.76226164 |
| 140 | Prominent nose (HP:0000448) | 1.75763231 |
| 141 | Mucopolysacchariduria (HP:0008155) | 1.74553909 |
| 142 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74553909 |
| 143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.74517852 |
| 144 | Microglossia (HP:0000171) | 1.74246534 |
| 145 | High pitched voice (HP:0001620) | 1.73980369 |
| 146 | Degeneration of anterior horn cells (HP:0002398) | 1.73715646 |
| 147 | Abnormality of the anterior horn cell (HP:0006802) | 1.73715646 |
| 148 | Axonal loss (HP:0003447) | 1.73204363 |
| 149 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.72202279 |
| 150 | Lower limb hyperreflexia (HP:0002395) | 1.71996403 |
| 151 | Ovarian neoplasm (HP:0100615) | 1.70758397 |
| 152 | Chronic diarrhea (HP:0002028) | 1.70729396 |
| 153 | Cystic hygroma (HP:0000476) | 1.70012782 |
| 154 | Autoimmune hemolytic anemia (HP:0001890) | 1.69899948 |
| 155 | Glioma (HP:0009733) | 1.69624956 |
| 156 | Cerebral aneurysm (HP:0004944) | 1.68936166 |
| 157 | Abnormality of the ileum (HP:0001549) | 1.68711848 |
| 158 | Decreased skull ossification (HP:0004331) | 1.68706321 |
| 159 | Thyroiditis (HP:0100646) | 1.68618715 |
| 160 | Hypergammaglobulinemia (HP:0010702) | 1.68497666 |
| 161 | Abnormality of the prostate (HP:0008775) | 1.68317014 |
| 162 | Follicular hyperkeratosis (HP:0007502) | 1.68003832 |
| 163 | Natal tooth (HP:0000695) | 1.67873481 |
| 164 | Hemoptysis (HP:0002105) | 1.67668715 |
| 165 | Abnormality of the preputium (HP:0100587) | 1.67615700 |
| 166 | Abnormality of eosinophils (HP:0001879) | 1.67559145 |
| 167 | Abnormality of the astrocytes (HP:0100707) | 1.67043504 |
| 168 | Astrocytoma (HP:0009592) | 1.67043504 |
| 169 | Uterine neoplasm (HP:0010784) | 1.66536925 |
| 170 | Lymphopenia (HP:0001888) | 1.66171528 |
| 171 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.65828834 |
| 172 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.65828834 |
| 173 | Disinhibition (HP:0000734) | 1.65696473 |
| 174 | Ectropion (HP:0000656) | 1.65330460 |
| 175 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.65244010 |
| 176 | Ependymoma (HP:0002888) | 1.64348493 |
| 177 | Tetraparesis (HP:0002273) | 1.62770077 |
| 178 | Narrow palate (HP:0000189) | 1.61284569 |
| 179 | Overlapping toe (HP:0001845) | 1.61066882 |
| 180 | Myelodysplasia (HP:0002863) | 1.60448907 |
| 181 | Neoplasm of the colon (HP:0100273) | 1.58899522 |
| 182 | Stillbirth (HP:0003826) | 1.58327043 |
| 183 | Ankle contracture (HP:0006466) | 1.58314333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 2.86445016 |
| 2 | CDK12 | 2.79044280 |
| 3 | JAK3 | 2.61012918 |
| 4 | LATS1 | 2.55461657 |
| 5 | MAP4K1 | 2.51783638 |
| 6 | MAP3K14 | 2.37348830 |
| 7 | TYK2 | 2.27069999 |
| 8 | BLK | 2.21255897 |
| 9 | STK10 | 2.14978059 |
| 10 | TAOK3 | 2.14550449 |
| 11 | EIF2AK1 | 2.12758251 |
| 12 | PKN2 | 2.01434305 |
| 13 | NUAK1 | 2.00189852 |
| 14 | BUB1 | 1.98192388 |
| 15 | EEF2K | 1.94520825 |
| 16 | TBK1 | 1.91521510 |
| 17 | EIF2AK3 | 1.89157317 |
| 18 | TRIM28 | 1.87767849 |
| 19 | ZAP70 | 1.86001013 |
| 20 | FGFR4 | 1.84126333 |
| 21 | TRIB3 | 1.83069937 |
| 22 | MAP3K10 | 1.82021035 |
| 23 | ERN1 | 1.80463225 |
| 24 | NEK1 | 1.78382632 |
| 25 | IRAK3 | 1.66076203 |
| 26 | PIK3CG | 1.58266132 |
| 27 | KIT | 1.56367727 |
| 28 | JAK1 | 1.56028703 |
| 29 | NEK9 | 1.55535615 |
| 30 | SRPK1 | 1.54659278 |
| 31 | FLT3 | 1.54496098 |
| 32 | STK3 | 1.54108617 |
| 33 | IKBKB | 1.52213145 |
| 34 | NEK2 | 1.51990568 |
| 35 | BMPR2 | 1.49731228 |
| 36 | CHUK | 1.49423619 |
| 37 | TXK | 1.49103253 |
| 38 | MKNK1 | 1.46073134 |
| 39 | PLK3 | 1.45955813 |
| 40 | MKNK2 | 1.44939659 |
| 41 | ERBB4 | 1.43636376 |
| 42 | RPS6KA4 | 1.41104080 |
| 43 | LRRK2 | 1.40955303 |
| 44 | IRAK4 | 1.39459313 |
| 45 | PTK6 | 1.38898976 |
| 46 | IKBKE | 1.38634393 |
| 47 | FGFR3 | 1.37015024 |
| 48 | NLK | 1.34543670 |
| 49 | BMPR1B | 1.31551873 |
| 50 | CDK6 | 1.30447336 |
| 51 | PIM1 | 1.30320170 |
| 52 | STK24 | 1.28371950 |
| 53 | CSF1R | 1.27873598 |
| 54 | BTK | 1.20930525 |
| 55 | CSK | 1.19615977 |
| 56 | MST1R | 1.18542275 |
| 57 | PIM2 | 1.16803677 |
| 58 | STK4 | 1.15795080 |
| 59 | EPHB1 | 1.13034029 |
| 60 | SCYL2 | 1.09791184 |
| 61 | RIPK4 | 1.09671331 |
| 62 | CDC7 | 1.09459990 |
| 63 | ERBB3 | 1.09265029 |
| 64 | FER | 1.08719900 |
| 65 | CDK4 | 1.07725827 |
| 66 | RIPK1 | 1.06654993 |
| 67 | MET | 1.06148275 |
| 68 | STK38L | 1.04041865 |
| 69 | HCK | 0.99097564 |
| 70 | TEC | 0.97510273 |
| 71 | ZAK | 0.97157990 |
| 72 | PAK4 | 0.96845834 |
| 73 | ITK | 0.96827581 |
| 74 | SYK | 0.95065486 |
| 75 | TESK1 | 0.93875008 |
| 76 | MAP2K3 | 0.93772798 |
| 77 | MAP3K2 | 0.92820497 |
| 78 | PDK2 | 0.92602932 |
| 79 | EPHA3 | 0.92380172 |
| 80 | MOS | 0.91898441 |
| 81 | TGFBR2 | 0.89741938 |
| 82 | LCK | 0.88361157 |
| 83 | CAMK1G | 0.88310158 |
| 84 | CLK1 | 0.88056931 |
| 85 | MATK | 0.86637590 |
| 86 | KSR1 | 0.86454392 |
| 87 | MAP3K8 | 0.85330877 |
| 88 | ATR | 0.84677975 |
| 89 | PDGFRA | 0.84666209 |
| 90 | MST4 | 0.84502852 |
| 91 | FGFR1 | 0.83790759 |
| 92 | MTOR | 0.81692854 |
| 93 | TTN | 0.81473269 |
| 94 | JAK2 | 0.81462766 |
| 95 | SIK1 | 0.80971183 |
| 96 | CDK7 | 0.80891868 |
| 97 | NME2 | 0.79340598 |
| 98 | STK39 | 0.78726160 |
| 99 | PLK1 | 0.78266373 |
| 100 | RAF1 | 0.78038911 |
| 101 | ICK | 0.77326943 |
| 102 | EPHA2 | 0.76050592 |
| 103 | LYN | 0.74168372 |
| 104 | CHEK2 | 0.73690041 |
| 105 | BMX | 0.72819299 |
| 106 | ALK | 0.72296399 |
| 107 | CAMK1D | 0.70436082 |
| 108 | MARK3 | 0.70114131 |
| 109 | RPS6KB2 | 0.68605038 |
| 110 | IRAK1 | 0.66092515 |
| 111 | MYLK | 0.65528356 |
| 112 | PBK | 0.65205847 |
| 113 | TRPM7 | 0.64895965 |
| 114 | DYRK3 | 0.64371477 |
| 115 | MAP3K13 | 0.64180579 |
| 116 | WEE1 | 0.62746274 |
| 117 | FRK | 0.61343350 |
| 118 | PDGFRB | 0.59745691 |
| 119 | TSSK6 | 0.59420970 |
| 120 | TAF1 | 0.57850729 |
| 121 | CAMKK2 | 0.57594592 |
| 122 | EGFR | 0.57306568 |
| 123 | TNIK | 0.56521642 |
| 124 | TGFBR1 | 0.56418732 |
| 125 | EIF2AK2 | 0.56247305 |
| 126 | PTK2 | 0.55635640 |
| 127 | AKT3 | 0.54843710 |
| 128 | CDK9 | 0.54160883 |
| 129 | TTK | 0.53247808 |
| 130 | KDR | 0.53189113 |
| 131 | WNK1 | 0.52665843 |
| 132 | FGFR2 | 0.52601320 |
| 133 | YES1 | 0.52037316 |
| 134 | AURKB | 0.51870800 |
| 135 | BRD4 | 0.51235655 |
| 136 | GRK6 | 0.51171701 |
| 137 | CDK8 | 0.50236796 |
| 138 | DMPK | 0.47837387 |
| 139 | MELK | 0.47631419 |
| 140 | FGR | 0.47243375 |
| 141 | PASK | 0.46959408 |
| 142 | GRK7 | 0.46652126 |
| 143 | MAP4K2 | 0.46223894 |
| 144 | MAPKAPK2 | 0.43689391 |
| 145 | DDR2 | 0.43293451 |
| 146 | PLK2 | 0.42753942 |
| 147 | DYRK1B | 0.41602310 |
| 148 | BRSK1 | 0.41597766 |
| 149 | ATM | 0.40913438 |
| 150 | PAK2 | 0.40461584 |
| 151 | CHEK1 | 0.40405984 |
| 152 | ABL1 | 0.40191079 |
| 153 | MAPK11 | 0.40079927 |
| 154 | MAP3K5 | 0.39717154 |
| 155 | ACVR1B | 0.37703592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 2.43296899 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38572619 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.24848998 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21382131 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.06877849 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99539167 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.98014401 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94793737 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87223877 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82616263 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78518425 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76501109 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.74972029 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71726725 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.67206599 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63602538 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61524032 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.59071970 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58239145 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.58021411 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57076654 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.52459995 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51705997 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51221405 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49142439 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47881676 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.43235082 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41732849 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.37282041 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.36113141 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.34092622 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34028818 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31648093 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.29665704 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28930717 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.26852787 |
| 37 | DNA replication_Homo sapiens_hsa03030 | 1.25613900 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25178003 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.24805579 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24619776 |
| 41 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.23920826 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22189367 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21773273 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21204868 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20983984 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20455307 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19795224 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18541854 |
| 49 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.16974187 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14975395 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13643219 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11020069 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08356136 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.08212126 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03558421 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03058707 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02723690 |
| 58 | Cell cycle_Homo sapiens_hsa04110 | 1.01894117 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00450182 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00209489 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98865579 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.98249666 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97286972 |
| 64 | * Lysosome_Homo sapiens_hsa04142 | 0.97241928 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96663244 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96487178 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96135677 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94424240 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90515425 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90381664 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90117218 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.90046325 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88689927 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88155798 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87936454 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.86909643 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86082510 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.85834983 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85765756 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.85395400 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85006164 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83865691 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83571082 |
| 84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81874221 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81794705 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81750773 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80264015 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79834763 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.74078557 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73951386 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72986616 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.70196127 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.70149151 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69910776 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.67873144 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67326306 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67061459 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65395212 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65085166 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64168476 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63484346 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63278651 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63256059 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.61002720 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60507265 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.60479707 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60030140 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58256674 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58242979 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58110962 |
| 111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57560842 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.57399456 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.56078582 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55688204 |
| 115 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55442286 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54875356 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53680822 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53496186 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53370217 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.53124830 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53039486 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52237760 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52153093 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52121747 |
| 125 | Focal adhesion_Homo sapiens_hsa04510 | 0.51856280 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51341575 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50686977 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50660434 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.50477216 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49819095 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48598600 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48578970 |
| 133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47136167 |
| 134 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46736287 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46181358 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45253986 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43814657 |
| 138 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43619190 |
| 139 | Spliceosome_Homo sapiens_hsa03040 | 0.42898718 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42658875 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41478700 |
| 142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40279685 |

